Passions

Playing the violin and piano

Film

Muay thai

Cooking

Skiing

Experience

Bavarian Nordic Acquires Emergent BioSolutions Travel Vaccines Portfolio

February 22, 2023

Bavarian Nordic, a vaccine company, has entered into a definitive agreement to acquire Emergent BioSolutions’ travel vaccines portfolio for up to $380 million, including an upfront payment of $270 million.

Read more

Related contacts

Michal Berkner
Partner, London
John Wilkinson
Partner, London
Jarrett Burks
Associate, London
Joe Sandys
Associate, London
Michael Fernando
Associate, London
Sydney Sawyier
Associate, London